Absence of exon 15 BRAF germline mutations in familial melanoma

被引:50
作者
Lang, J [1 ]
Boxer, M
MacKie, R
机构
[1] Duncan Guthrie Inst Med Genet, Glasgow G3 8SJ, Lanark, Scotland
[2] Univ Glasgow, Dept Publ Hlth, Glasgow, Lanark, Scotland
关键词
melanoma; familial; BRAF; tumor; cancer; CDKN2A; MC1R;
D O I
10.1002/humu.10188
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
We have analyzed DNA from peripheral blood of 42 cases of familial melanoma for germline mutations in exon 15 of the BRAF gene. No evidence of mutation was found. We have also analyzed DNA extracted from secondary melanoma from two members of these families. These results were also negative. In addition we have searched for exon 15 BRAF mutations in 24 samples of secondary melanoma from 22 cases of sporadic melanoma and detected the 1796T >A BRAF mutation which leads to a substitution of valine by glutamic acid at position 599 (V599E) in six samples. Peripheral blood DNA from two of these tumor-positive cases of sporadic melanoma were negative for the V599E BRAF mutation. This mutation therefore appears to be a somatic mutation associated with melanoma development and/or progression in a proportion of affected individuals.
引用
收藏
页码:327 / 330
页数:4
相关论文
共 9 条
[1]  
Bishop DT, 2002, J NATL CANCER I, V94, P894, DOI 10.1093/jnci/94.12.894
[2]   Mutations of the BRAF gene in human cancer [J].
Davies, H ;
Bignell, GR ;
Cox, C ;
Stephens, P ;
Edkins, S ;
Clegg, S ;
Teague, J ;
Woffendin, H ;
Garnett, MJ ;
Bottomley, W ;
Davis, N ;
Dicks, N ;
Ewing, R ;
Floyd, Y ;
Gray, K ;
Hall, S ;
Hawes, R ;
Hughes, J ;
Kosmidou, V ;
Menzies, A ;
Mould, C ;
Parker, A ;
Stevens, C ;
Watt, S ;
Hooper, S ;
Wilson, R ;
Jayatilake, H ;
Gusterson, BA ;
Cooper, C ;
Shipley, J ;
Hargrave, D ;
Pritchard-Jones, K ;
Maitland, N ;
Chenevix-Trench, G ;
Riggins, GJ ;
Bigner, DD ;
Palmieri, G ;
Cossu, A ;
Flanagan, A ;
Nicholson, A ;
Ho, JWC ;
Leung, SY ;
Yuen, ST ;
Weber, BL ;
Siegler, HF ;
Darrow, TL ;
Paterson, H ;
Marais, R ;
Marshall, CJ ;
Wooster, R .
NATURE, 2002, 417 (6892) :949-954
[3]  
Elwood JM, 1997, INT J CANCER, V73, P198, DOI 10.1002/(SICI)1097-0215(19971009)73:2<198::AID-IJC6>3.0.CO
[4]  
2-R
[5]   Recent trends in cutaneous melanoma incidence among whites in the United States [J].
Jemal, A ;
Devesa, SS ;
Hartge, P ;
Tucker, MA .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (09) :678-683
[6]   Incidence of and survival from malignant melanoma in Scotland: an epidemiological study [J].
MacKie, RM ;
Bray, CA ;
Hole, DJ ;
Morris, A ;
Nicolson, M ;
Evans, A ;
Doherty, V ;
Vestey, J .
LANCET, 2002, 360 (9333) :587-591
[7]   CDKN2A germline mutations in UK patients with familial melanoma and multiple primary melanomas [J].
MacKie, RM ;
Andrew, N ;
Lanyon, WG ;
Connor, JM .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 111 (02) :269-272
[8]   Trends in the incidence of cutaneous malignant melanoma in New South Wales, 1983-1996 [J].
Marrett, LD ;
Nguyen, HL ;
Armstrong, BK .
INTERNATIONAL JOURNAL OF CANCER, 2001, 92 (03) :457-462
[9]   Melanocortin-1 receptor polymorphisms and risk of melanoma: Is the association explained solely by pigmentation phenotype? [J].
Palmer, JS ;
Duffy, DL ;
Box, NF ;
Aitken, JF ;
O'Gorman, LE ;
Green, AC ;
Hayward, NK ;
Martin, NG ;
Sturm, RA .
AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 66 (01) :176-186